The new codes released Aug. 10 that will first appear in CPT 2012, with an implementation date of Jan. 1, 2011, are:
Patient Management
• 0550F Cytopathology report on routine nongynecologic specimen finalized within two working days of accession date
• 0555F Symptom management plan of care documented
• 0556F Plan of care to achieve lipid control documented
• 0557F Plan of care to manage anginal symptoms documented
Patient History
• 1010F Severity of angina assessed by level of activity
• 1011F Angina present
• 1012F Angina absent
• 1031F Smoking status and exposure to second hand smoke in the home assessed
• 1032F Current tobacco smoker OR currently exposed to secondhand smoke
• 1033F Current tobacco non-smoker AND not currently exposed to secondhand smoke
• 1175F Functional status for dementia assessed and results reviewed
• 1181F Neuropsychiatric symptoms assessed and results reviewed
• 1182F Neuropsychiatric symptoms, one or more present
• 1183F Neuropsychiatric symptoms, absent
• 1450F Symptoms improved or remained consistent with treatment goals since last assessment
• 1451F Symptoms demonstrated clinically important deterioration since last assessment
• 1460F Qualifying cardiac event/diagnosis in previous 12 months
• 1461F No qualifying cardiac event/diagnosis in previous 12 months
• 1490F Dementia severity classified, mild
• 1493F Dementia severity classified, severe
• 1494F Cognition assessed and reviewed
Physical Examination
• 2015F Asthma impairment assessed
• 2016F Asthma risk assessed
Diagnostic/Screening Processes or Results
• 3019F Left ventricular ejection fraction (LVEF) assessment planned post discharge
• 3055F Left ventricular ejection fraction (LVEF) less than or equal to 35 percent
• 3056F Left ventricular ejection fraction (LVEF) greater than 35 percent or no LVEF result available
• 3115F Quantitative results of an evaluation of current level of activity and clinical symptoms
• 3117F Heart Failure disease specific structured assessment tool completed
• 3118F New York Heart Association (NYHA) Class documented
• 3119F No Evaluation of level of activity or clinical symptoms
• 3725F Screening for depression performed
Therapeutic, Preventive, or Other Interventions
• 4008F Beta-Blocker therapy prescribed or currently being taken
• 4010F Angiotensin converting enzyme (ACE) inhibitor or Angiotensin Receptor Blocker (ARB) therapy prescribed or currently being taken
• 4013F Statin therapy prescribed or currently being taken
• 4086F Aspirin or clopidogrel prescribed
• 4140F Inhaled corticosteroids prescribed
• 4144F Alternative long-term control medication prescribed
• 4145F Two or more anti-hypertensive agents prescribed or currently being taken
• 4322F Caregiver provided with education and referred to additional resources for support
• 4350F Counseling provided on symptom management, end of life decisions, and palliation
• 4450F Self-care education provided to patient
• 4470F Implantable Cardioverter-Defibrillator (ICD) counseling provided
• 4480F Patient receiving ACE Inhibitor/ARB Therapy and Beta-Blocker Therapy for three months or longer
• 4481F Patient receiving ACE Inhibitor/ARB Therapy and Beta-Blocker Therapy for less than three months
• 4500F Referred to an outpatient cardiac rehabilitation program
• 4510F Previous cardiac rehabilitation for qualifying cardiac event completed
• 4525F Neuropsychiatric intervention ordered
• 4526F Neuropsychiatric intervention received
Follow-up or Other Outcomes
• 5250F Asthma discharge plan present
The new codes released August 10 that will first appear in CPT® 2013, with an implementation date of Jan. 1, 2012, are:
Patient History
• 1052F Type, anatomic location and activity all assessed
Diagnostic/Screening Processes or Results
• 3095F Dual-energy X-Ray Absorptiometry (DXA) results documented
• 3096F Central Dual-energy X-Ray Absorptiometry (DXA) ordered
• 3216F Patient has documented immunity to Hepatitis B
• 3517F Hepatitis B Virus (HBV) status assessed and results interpreted within one year prior to receiving a first course of anti-TNF (tumor necrosis factor) therapy
• 3520F Clostridium difficile testing performed
• 3750F Patient not receiving dose of corticosteroids greater than or equal to 10mg/day* for 60 or greater consecutive days
Therapeutic, Preventive, or Other Interventions
• 4069F Venous thromboembolism (VTE) prophylaxis received
• 4142F Corticosteroid sparing therapy prescribed
• 6150F Patient not receiving a first course of anti-TNF (tumor necrosis factor) therapy
Read the AAPC report on CPT Category II updates.
Related Articles on Coding, Billing and Collections:
Washington Fines Regence BlueShield $100,000 for Denying Coverage for IUD Removal
AdvantEdge Healthcare Solutions to Offer Compliance Training to Students at Maryland University
Changes to Georgia Insurance Plan Expected to Close $800M Budget Gap
